• Explore /
  • Poster
  • / First-line immunochemotherapy for follicular lymphoma in the GALLIUM study: Prognostic value of PET-CT status after long-term follow-up.

First-line immunochemotherapy for follicular lymphoma in the GALLIUM study: Prognostic value of PET-CT status after long-term follow-up.

Abstract Poster

Authors

null

Tina Nielsen

F. Hoffmann-La Roche Ltd., Basel, Switzerland

Tina Nielsen , Sally Barrington , Michel Meignan , Deniz Sahin , Andrea Knapp , Anastasiia Kinkolykh , Michael Herold , Wolfgang Hiddemann , Robert Marcus , Judith Trotman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Chronic Lymphocytic Leukemia (CLL) and Hairy Cell

Clinical Trial Registration Number

NCT01332968

Citation

J Clin Oncol 38: 2020 (suppl; abstr 8025)

DOI

10.1200/JCO.2020.38.15_suppl.8025

Abstract #

8025

Poster Bd #

358

Abstract Disclosures

Similar Posters

First Author: Miguel Angel A. Canales Albendea

First Author: William Townsend

First Author: Eliza Anne Hawkes

First Author: Carla Casulo